Clinical trial Recruiting at 1 site Interventional Ages 18 and up

A-PRF+ with Xenograft vs Collagen Membrane with Xenograft for Degree II Furcation Defects in Mandibular Molars

Official title: Efficacy of Platelet-Rich Fibrin Combined With Xenograft in the Treatment of Mandibular Molar Furcation Involvements

Run by University of Medicine and Pharmacy at Ho Chi Minh City · NCT07764029 · Data updated 2026-11-12

This trial tests whether using advanced platelet-rich fibrin with a xenograft works better than a collagen membrane with a xenograft to treat degree II furcation defects in lower first molars of adults with periodontitis.

More Periodontitis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment22 (estimated)
SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City
Academic / other
Locations1 site (Ho Chi Minh City, Ho Chi Minh City (HCMC))
StatusRecruiting
StartedJune 25, 2026
Main results expectedJune 1, 2027
Study endsJune 30, 2027
Registry record updatedAugust 14, 2026
Trial IDNCT07764029 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with periodontitis, a mandibular molar with Hamp degree II furcation involvement and PPD ≥ 5 mm after non-surgical therapy, good oral hygiene, and keratinized gingiva ≥ 2 mm.

Probably not a fit

Patients with poor oral hygiene, complex endodontic conditions, occlusal trauma, or furcation anatomy not meeting inclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares two regenerative approaches for mandibular molar degree II furcation involvements in adults with periodontitis. Participants undergo open flap debridement and receive either A-PRF+ mixed with Cerabone xenograft covered by an A-PRF+ membrane, or a xenograft covered by a resorbable collagen membrane. Outcomes include clinical periodontal healing, radiographic bone regeneration via CBCT, and patient-reported outcomes (pain and satisfaction) assessed over 6 months, along with changes in the TWEAK biomarker in gingival crevicular fluid. Baseline and 6-month follow-up measurements will include probing depths, attachment levels, recession, plaque and gingival indices, and CBCT-derived bone metrics.

Why it matters

Potential benefit: If successful, the A-PRF+ with xenograft approach could enhance bone fill and healing in challenging furcation defects, potentially improving tooth stability and patient comfort.

How similar studies have gone: Prior similar regenerative approaches have shown favorable outcomes in furcation treatment, but this exact combination (A-PRF+ with Cerabone vs collagen membrane with Cerabone) is novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients over 18 years old
* Patients diagnosed with periodontitis who have completed non-surgical treatment: scaling and root planing
* Patients attending a follow-up visit at least 5 weeks after non-surgical treatment, demonstrating compliance and good oral hygiene cooperation
* Presence of a mandibular molar with a Degree II furcation involvement according to Hamp (1975), presenting a residual periodontal pocket at the buccal site (PPD ≥ 5mm) after non-surgical treatment, and showing radiolucency in the furcation area on CBCT imaging
* Plaque Index (PlI) \< 1 following non-surgical treatment
* Width of keratinized gingiva ≥ 2mm
* Teeth with furcation defects where gingival recession does not extend apically beyond the buccal furcation fornix (no supragingival furcation exposure)
* Teeth without occlusal trauma, pulpal or periapical pathologies, and no combined periodontic-endodontic lesions
* Degree II furcation involvement according to Hamp (1975) and Subclass A or B according to Tarnow and Fletcher (1984)
* The defect is located apical to the interproximal alveolar bone crest on CBCT imaging

Exclusion Criteria:

* Patients with systemic diseases affecting periodontal treatment outcomes, such as: diabetes mellitus, heart disease requiring anticoagulant therapy, blood disorders, immunodeficiency, etc
* Pregnant or lactating patients
* Patients who have used antibiotics or any other medications affecting periodontal treatment outcomes within the last 6 months
* Patients who smoke tobacco.
* Patients who have used aspirin or medications affecting blood coagulation within 2 weeks prior to the blood collection for PRF preparation
* Patients with a history of allergy to local anesthetics
* Defects associated with grade II tooth mobility that has not been splinted, or grade III tooth mobility according to Miller (2014)

Where it's running

  • Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City
    Ho Chi Minh City, Ho Chi Minh City (HCMC), Vietnam
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.